Fulcrum Therapeutics
FULC
FULC
110 hedge funds and large institutions have $648M invested in Fulcrum Therapeutics in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 41 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.65% more ownership
Funds ownership: 92.98% → 94.63% (+1.6%)
36% less capital invested
Capital invested by funds: $1.01B → $648M (-$362M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
110
Holding in Top 10
2
Calls
$2.24M
Puts
$1.22M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$12.1M | |
| 3 | +$10M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.55M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$7.67M |
Top Sellers
| 1 | -$44M | |
| 2 | -$35.3M | |
| 3 | -$17.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$8.64M |
| 5 |
N
Natixis
Paris,
France
|
-$7.11M |